However, the expression of CCND2 or CCND3 without the presence of a detectable translocation, particularly in SOX11-negative tumours, should not be considered as evidence of MCL since B cell neoplasms express variable levels of CCND2 or CCND3 without translocations of these genes [53]. This evidence concerns the gene CCND3 and mantle cell lymphoma.